Literature DB >> 7908796

Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.

J I Tsao1, R L Rossi, J A Lowell.   

Abstract

OBJECTIVE: To assess the adequacy of pylorus-preserving pancreatoduodenectomy (PPPD) as a definitive surgical treatment for primary malignant diseases of the periampullary region.
DESIGN: Retrospective review of the clinical records of patients undergoing PPPD for malignant diseases of the periampullary region. Median and 5-year actuarial survival by type and stage of cancer were determined. Survival data from this study were compared with those of patients undergoing a conventional Whipple operation.
SETTING: Lahey Clinic, Burlington, Mass. STUDY PARTICIPANTS: One hundred six patients undergoing PPPD for primary malignant disease of the periampullary region between November 1979 and June 1992. INTERVENTION: Pylorus-preserving pancreatoduodenectomy was performed with curative intent in the 106 patients. Ninety-five patients underwent proximal pancreatectomy; 11 patients, total pancreatectomy. Resection of the portal vein was performed in 10 patients. MAIN OUTCOME MEASURE: Long-term survival following PPPD was analyzed with respect to the type and stage of cancer. Median follow-up was 30 months (range, 6 to 156 months).
RESULTS: Five-year actuarial survival rates were 45.4% for patients with ampullary adenocarcinoma; 6.6%, with pancreatic ductal adenocarcinoma; 33.3%, with distal bile duct adenocarcinoma; 75%, with pancreatic islet cell adenocarcinoma; and 0%, with pancreatic cystadenocarcinoma. An early cancer stage was associated with more favorable survival for ampullary and distal bile duct adenocarcinomas. For pancreatic ductal adenocarcinoma only, tumors less than 2 cm were associated with better survival. Duodenal resection margins were free of disease in all patients, while peripancreatic and retroperitoneal extension of the tumor was found in 20%.
CONCLUSION: For patients with periampullary malignant disease, long-term survival following PPPD is similar to that following a conventional Whipple operation. The potential benefits of hemigastrectomy with perigastric lymphadenectomy are frequently obviated by the presence of positive margins and lymph nodes elsewhere, ie, in the retroperitoneum. We advocate PPPD as the procedure of choice for locally resectable malignant disease of the periampullary region, provided the duodenal margin is viable and tumor free.

Entities:  

Mesh:

Year:  1994        PMID: 7908796     DOI: 10.1001/archsurg.1994.01420280081010

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  26 in total

1.  Pancreaticojejunal bridge-anastomosis: a novel option for surgeon to preserve pancreatic body and tail in urgent reoperation for intra-abdominal massive hemorrhage after pancreaticoduodenectomy.

Authors:  Jin Xu; Xianwei Dai; Xianmin Bu; Feng Gao; Xiaobo Zhang
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

2.  Pancreatic resection for pancreatic cancer.

Authors:  Jeannine Bachmann; Christoph W Michalski; Marc E Martignoni; Markus W Büchler; Helmut Friess
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 3.  Current management of pancreatic carcinoma.

Authors:  K D Lillemoe
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

4.  Distal pancreatectomy with en bloc resection of the celiac artery for carcinoma of the body and tail of the pancreas.

Authors:  T Mayumi; Y Nimura; J Kamiya; S Kondo; M Nagino; M Kanai; M Miyachi; K Hamaguchi; N Hayakawa
Journal:  Int J Pancreatol       Date:  1997-08

Review 5.  Adjuvant pharmacotherapy in the management of elderly patients with pancreatic cancer.

Authors:  Raphaël Maréchal; Anne Demols; Jean-Luc Van Laethem
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

6.  A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators.

Authors:  Richard Kim; Raymond Tsao; Ann Tan; Mike Byrne; Khaldoun Almhanna; Aleksander Lazaryan; Paul Elson; Robert J Pelley
Journal:  J Gastrointest Surg       Date:  2010-05-06       Impact factor: 3.452

7.  Adenocarcinoma of the ampulla of Vater. A 28-year experience.

Authors:  M A Talamini; R C Moesinger; H A Pitt; T A Sohn; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

8.  Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer.

Authors:  Ryuichiro Doi; Kazuhiro Kami; Daisuke Ito; Koji Fujimoto; Yoshiya Kawaguchi; Michihiko Wada; Masafumi Kogire; Ryo Hosotani; Masayuki Imamura; Shinji Uemoto
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

Review 9.  Quality of complication reporting in the surgical literature.

Authors:  Robert C G Martin; Murray F Brennan; David P Jaques
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

Review 10.  Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis.

Authors:  Markus Schäfer; Beat Müllhaupt; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.